Clinical Trials Browser

Not yet recruiting × Ovarian Neoplasms × Hyperthermic Intraperitoneal Chemotherapy × Clear all

NCT06544460 2024-08-09

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

Phase 2 Not yet recruiting

Ovarian Neoplasms